Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia.
Saved in:
| Title: | Dose optimization of single-agent inotuzumab ozogamicin in adults with relapsed/refractory acute lymphoblastic leukemia. |
|---|---|
| Authors: | DeAngelo, Daniel J.1 (AUTHOR), Chen, Ying2 (AUTHOR), Cassaday, Ryan D.3 (AUTHOR), Hibma, Jennifer E.2 (AUTHOR), Yang, Derek Z.2 (AUTHOR), Garrett, May2 (AUTHOR), Zhang, Fan2 (AUTHOR), Dimitrov, Svetoslav H.2 (AUTHOR), Vandendries, Erik R.2 (AUTHOR), Kantarjian, Hagop M.4 (AUTHOR) hkantarjian@mdanderson.org |
| Source: | Leukemia & Lymphoma. Aug2026, p1-11. 11p. 3 Illustrations. |
| Database: | Academic Search Ultimate |
Be the first to leave a comment!
